Chantix Recall Expanded To U.S. Products Due To N-Nitroso Varenicline Contamination
Pfizer is recalling 12 lots of Chantix due to excessive levels of N-nitroso-varenicline, which may cause cancer in humans.
Pfizer is recalling 12 lots of Chantix due to excessive levels of N-nitroso-varenicline, which may cause cancer in humans.
The FDA has issued new guidance on how industry should work to avoid further contamination by NDMA and similar carcinogens.